Dialysis Patient Citizens Issues Statement on Passing of Congressman Donald Payne Jr.
PR Newswire
Rep. Payne Received Dialysis Treatment and Supported DPC Advocacy Efforts
WASHINGTON, April 24, 2024 /PRNewswire/ -- Today, Dialysis Patient Citizens (DPC) Board President Andrew Conkling issued the following statement on the passing of Rep. Donald Payne Jr. (D-NJ). Rep. Payne received dialysis treatment, advocated for better care and insurance coverage for dialysis patients, and spoke at a DPC advocacy event in Washington, DC.
"We are deeply saddened to learn of the passing of Congressman Payne, who was a true friend to Dialysis Patient Citizens and a tireless advocate for dialysis patients across the country," said DPC Board President Andrew Conkling. "Despite his ongoing health challenges, including end-stage renal disease (ESRD), Congressman Payne made the time and effort to fight for dialysis patients like himself. He understood the health and financial challenges ESRD patients face, and used his personal experience to educate others in Congress and push for policies that would improve the lives of countless individuals. All of us at DPC are eternally grateful for his friendship, advocacy, and public service. Our thoughts are with his loved ones and all who had the pleasure of knowing him."
DPC is the leading advocacy organization for dialysis patients nationwide. For more information about DPC, click here.
Community Health Systems, Inc. Announces First Quarter Ended March 31, 2024 Results
Univest Financial Corporation Reports First Quarter Results
Advisor News
- Addressing the ‘menopause tax:’ A guide for advisors with female clients
- Alternative investments in 401(k)s: What advisors must know
- The modern advisor: Merging income, insurance, and investments
- Financial shocks, caregiving gaps and inflation pressures persist
- Americans unprepared for increased longevity
More Advisor NewsAnnuity News
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Aspida Life and WealthVest Offer a Powerful New Guaranteed Income Product with the WealthLock® Income Builder
- Lack of digital tools drives wedge between insurers, advisors
- LIMRA: Annuity sales notch 10th consecutive $100B+ quarter
- AIG to sell remaining shares in Corebridge Financial
More Annuity NewsHealth/Employee Benefits News
- Studies from Denise Wolff et al Have Provided New Data on Atopic Dermatitis (AMCP Market Insights: Beyond skin deep on the role of managed care in moderate to severe atopic dermatitis): Skin Diseases and Conditions – Atopic Dermatitis
- New Clinical Trials and Studies Findings from RAND Corporation Described (Benefit design and consumer information: results from a randomized trial): Clinical Research – Clinical Trials and Studies
- School, BOCES healthcare costs up 22%, here’s why
- Healthcare cuts threaten Sullivan's reelection chances in Alaska
- Health insurance marketplace feels growing tremors from GOP cuts
More Health/Employee Benefits NewsLife Insurance News
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Dan Scholz to receive NAIFA’s Terry Headley Lifetime Defender Award
- Best’s Special Report: US Property/Casualty and Health Insurers Exceed Cost of Capital; Life Insurers Narrowly Miss
- Aspida Life and WealthVest Offer a Powerful New Guaranteed Income Product with the WealthLock® Income Builder
- Lack of digital tools drives wedge between insurers, advisors
More Life Insurance News